CO6390087A2 - Composición que comprende ácido caftárico y/o derivados del mismo - Google Patents

Composición que comprende ácido caftárico y/o derivados del mismo

Info

Publication number
CO6390087A2
CO6390087A2 CO11087831A CO11087831A CO6390087A2 CO 6390087 A2 CO6390087 A2 CO 6390087A2 CO 11087831 A CO11087831 A CO 11087831A CO 11087831 A CO11087831 A CO 11087831A CO 6390087 A2 CO6390087 A2 CO 6390087A2
Authority
CO
Colombia
Prior art keywords
derivatives
composition
acid
same
caftaric acid
Prior art date
Application number
CO11087831A
Other languages
English (en)
Inventor
Rachid Bel-Rhlid
Vanessa Crespy
Dominique Piguet
Maricel Marin-Kuan
Rene Fumeaux
Nicole Page-Zoerkler
Thomas Wolfgang Raab
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CO6390087A2 publication Critical patent/CO6390087A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)

Abstract

La presente invención se refiere de manera general al campo de alimentos y bebidas. En particular, se proporciona por ejemplo, una composición que permite suministrar ácido tartárico y/o caféico a un sujeto. Una modalidad de la presente invención es una composición que comprende un ingrediente que contiene ácido caftárico y/o derivados del mismo, y una bacteria de ácido láctico capaz de hidrolizar ácido caftárico y/o derivados del mismo para generar ácido tartárico y/o caféico.
CO11087831A 2009-01-27 2011-07-13 Composición que comprende ácido caftárico y/o derivados del mismo CO6390087A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09151383A EP2210505A1 (en) 2009-01-27 2009-01-27 Composition comprising caftaric acid and/or derivatives thereof

Publications (1)

Publication Number Publication Date
CO6390087A2 true CO6390087A2 (es) 2012-02-29

Family

ID=40670988

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11087831A CO6390087A2 (es) 2009-01-27 2011-07-13 Composición que comprende ácido caftárico y/o derivados del mismo

Country Status (14)

Country Link
US (1) US20120020926A1 (es)
EP (2) EP2210505A1 (es)
JP (1) JP2012515542A (es)
KR (1) KR20110119724A (es)
CN (1) CN102333459A (es)
AR (1) AR075187A1 (es)
AU (1) AU2010209806A1 (es)
BR (1) BRPI1007413A2 (es)
CA (1) CA2750686A1 (es)
CO (1) CO6390087A2 (es)
MX (1) MX2011007472A (es)
RU (1) RU2011135795A (es)
WO (1) WO2010086331A2 (es)
ZA (1) ZA201106299B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2012155852A (ru) * 2010-06-30 2014-06-27 Нестек С.А. Применение цикориевой кислоты и её производных для регулирования пигментации кожи
WO2012000963A1 (en) * 2010-06-30 2012-01-05 Nestec S.A. Use of caftaric acid and lactic bacterium in food supplement for regulating skin pigmentation
CN103025308B (zh) * 2010-06-30 2017-04-05 雀巢产品技术援助有限公司 咖啡酰酒石酸及衍生物在食品补充剂中用于调节皮肤色素沉着的用途
US20140065116A1 (en) * 2011-03-17 2014-03-06 Giovanni Mogna Probiotic bacteria having antioxidant activity and use thereof
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
CN102531902A (zh) * 2011-10-20 2012-07-04 沈阳双鼎制药有限公司 一种咖啡酰酒石酸及其制备方法和用途
EP2863929B1 (en) * 2012-06-22 2016-07-20 Nestec S.A. Probiotic and polyphenol against neurodegeneration
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
KR20170032815A (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
KR102475667B1 (ko) * 2020-08-07 2022-12-07 김성수 유산균을 포함하는 스트레스 완화, 수면 장애 개선 및 숙면 유지용 조성물
CN112870234B (zh) * 2021-01-27 2023-06-02 四川九章生物科技有限公司 包含绿原酸的药物组合物在制备治疗病理性黄疸的药物中的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5799193A (en) * 1980-12-08 1982-06-19 Kikkoman Corp Novel enzyme hydrolyzing hydroxy cinnamic ester and its preparation
FR2591073B1 (fr) * 1985-12-10 1988-02-19 Leroux Sarl Chicoree Boisson a base de chicoree et procede de preparation de ladite boisson
CN1211188A (zh) * 1996-02-14 1999-03-17 普罗克特和甘保尔公司 用于泌尿生殖道和肠道疾病的组合物
US20030185811A1 (en) * 2001-02-06 2003-10-02 Steve Teasdale Herbal extract and preparation thereof
FR2827774B1 (fr) * 2001-07-30 2005-06-24 Dolisos Lab Preparations pharmaceutiques et/ou dietetiques contenant un extrait vegetal titre en composes actifs et des micro-organismes probiotiques
JP2003250528A (ja) * 2002-03-06 2003-09-09 Yakult Honsha Co Ltd ビフィドバクテリウム属細菌の生残性改善剤、増殖促進剤、又は、同細菌含有醗酵物の製造方法
US6953574B2 (en) * 2002-06-21 2005-10-11 Technology Commercialization, Inc. Method for producing a fermented hydrolyzed medium containing microorganisms
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
EP1610623B1 (en) * 2003-03-25 2011-11-23 Aarhus Universitet Methodologies for improving the quality of meat, health status of animals and impact on environment
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
FR2886817B1 (fr) * 2005-06-10 2007-08-24 Gervais Danone Sa Produit alimentaire enrichi en probiotique et appauvri en acides organiques
NZ567333A (en) * 2005-09-28 2010-03-26 Constellation Brands Inc Grape extract, dietary supplement thereof, and processes therefor
FR2904935A1 (fr) * 2006-08-18 2008-02-22 Centre Nat Rech Scient Composition antidiabetique apte a stimuler la secretion d'insuline et destinee au traitement du diabete de type 2 (diabete non insulino-dependant).
FR2906109B1 (fr) * 2006-09-22 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire pour la prevention et la lutte contre les infections urinaires
ATE433675T1 (de) * 2006-10-13 2009-07-15 Gervais Danone Sa Neue zusammensetzung zur verbesserung des hautzustandes und verfahren zu ihrer herstellung
JP4990297B2 (ja) * 2007-02-01 2012-08-01 株式会社Ｔｋバイオ研究所 ブドウ果皮・種子乳酸菌発酵物及びそれを利用した医薬

Also Published As

Publication number Publication date
CN102333459A (zh) 2012-01-25
AU2010209806A1 (en) 2011-07-28
EP2210505A1 (en) 2010-07-28
ZA201106299B (en) 2014-01-29
KR20110119724A (ko) 2011-11-02
US20120020926A1 (en) 2012-01-26
EP2391230A2 (en) 2011-12-07
BRPI1007413A2 (pt) 2015-08-25
MX2011007472A (es) 2011-08-03
RU2011135795A (ru) 2013-03-10
AR075187A1 (es) 2011-03-16
WO2010086331A3 (en) 2010-09-30
CA2750686A1 (en) 2010-08-05
WO2010086331A2 (en) 2010-08-05
JP2012515542A (ja) 2012-07-12

Similar Documents

Publication Publication Date Title
CO6390087A2 (es) Composición que comprende ácido caftárico y/o derivados del mismo
CO6400174A2 (es) Composición que comprende ácido chicórico y/o derivados del mismo
AR085943A1 (es) Composicion antimicrobiana
IN2015DN01198A (es)
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
MX2015017994A (es) Metodos de conservacion biologica para bebidas y otros alimentos.
EP2705140B8 (de) Neue milchsäurebakterien und diese enthaltende zusammensetzungen
MX2013011430A (es) Bebida proteica y método para su preparación.
AR071426A1 (es) Extracto de cafe
NZ595939A (en) Use of modified peptide gamma-glu-abu for imparting or enhancing food or beverage taste
BR112012033212A2 (pt) uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica
RS54919B1 (sr) Bakterija za upotrebu kao probiotik za nutritivne i medicinske primene
IN2012DN01638A (es)
IN2014DN07483A (es)
PL2753687T3 (pl) Szczepy bakterii kwasu mlekowego i/lub bifidobakterii hamujących/zmniejszających wzrost różnych biotypów E. coli i różnych biotypów bakterii z rodzaju Clostridium
HRP20190162T1 (hr) Lactobacillus reuteri atcc pta 6475 za uporabu za sprječavanje ili liječenje gubitka kosti kod sisavaca
HK1219501A1 (zh) 新型乳酸菌、以新型乳酸菌作為有效成分的天然免疫活化劑以及含有新型乳酸菌的飲食品
PE20100127A1 (es) Composiciones para preparar una bebida
IN2012DN02283A (es)
MX2014001329A (es) Uso de bacterias de acido lactico para reducir patogenos y como un biodesinfectante.
UY32638A (es) Manoproteínas para uso en zumo de frutas
CL2012002781A1 (es) Producto que comprende un cuerpo de alimento compuesto por un componente de alimento y un componente de infusion que contiene mal todextrina en una concentracon de 5 a 65% con respecto al cuerpo del alimento; producto alimenticio; metodo para producir un cuerpo de alimento infusionado; y formulaciones de infusion.
WO2012054743A3 (en) Taste modifying compositions
PH12014501239A1 (en) Thymol and totarol antibacterial composition
MX2014006574A (es) Formulaciones de acamprosato, metodos de uso de las mismas, y combinaciones que comprenden las mismas.

Legal Events

Date Code Title Description
FC Application refused